Sterilin Limited has announced that its handy ward/shelf packs of its best selling 30ml universal containers are now available in a new pack of 50. The containers are CE marked and have a leak tight cap that ensures sample containment. Manufactured aseptically under clean room conditions from non-cytotoxic materials such as virgin polystyrene, the containers are processed in a manner that excludes microbiological contamination. They are used for preservation of urine samples and are available empty or pre-filled with boric acid.

Zila, Inc. has announced that its new oral screening technology ViziLite Plus, will be exclusively distributed by DentalMed Russian Alliance in Russia and Belarus. The Russian company will also be distributing TBlue(TM), the oral cancer screening product owned by Zila. DentalMed has begun the registration for the product and will start training its sales representatives and preparing the market for the product launch. ViziLite Plus utilizes a chemiluminescent light source and a patented vital tissue dye (TBlue). It will help dentists to identify and evaluate abnormalities in the mouth that have the potential to harbor pathological changes. The ViziLite Plus is a non-invasive exam It does  not cause much discomfort and is over in just a few minutes.

A clinical study has found Derma Sciences, Inc.’s key product, MEDIHONEY(TM), Wound & Burn Dressing with Active Leptospermum Honey, to be significantly beneficial in healing stalled venous leg ulcers, a first of its kind development in standard treatment ( compression therapy) of the ulcers. This will be extremely helpful in giving relief to patients suffering from chronic wounds for long periods.

Cook Medical has launched the Ciaglia Blue Dolphin™ Balloon Percutaneous Tracheostomy Introducer – the world’s first one-step device for percutaneous tracheostomy(PCT) procedures. PCTs are generally performed when there is the need for long term ventilation, for example, those undergoing surgery to the head and neck. The procedure is safe, but can have complications. The device minimizes this risk to the patient by combining balloon dilation and tracheal tube insertion. Designed in collaboration with experts in Critical Care medicine the Ciaglia Blue Dolphin reduces the risk of the three most common complications of the procedure: bleeding, tracheal ring fracture and posterior wall injury.

A novel device coating for urinary catheters (tubes inserted into the body to allow draining) can prove to be beneficial in lowering the risk of infection. The use of medical devices inserted into a patient’s body, often lead to complications that may lead to an increase in the time for which a patient is hospitalized or even more adverse cases, especially in patients who need the catheters to be inserted in the bladder for a long period as bacterial crusts form on the tubes, causing discomfort during removal. The coating developed at Queen’s University in Belfast self-cleanse the catheter when it becomes infected with bacteria.

The Ohio Board of Nursing issued a ruling in favor of allowing nurses operating within the limits of proper medical facility to administer Botox injections. The guideline was laid down after a Columbus, Ohio cosmetic surgeon Dr. Fernando Colon had submitted a request to the board last year stating that it was safe for the nurses to administer the injectables. The board requires the nurses just to complete a training session. Allergan, the maker of Botox injections will definitely gain from the ruling.